ID   GDPD2_HUMAN             Reviewed;         539 AA.
AC   Q9HCC8; B4DRH4; B4DVC9; Q9NXJ6;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=Glycerophosphoinositol inositolphosphodiesterase GDPD2;
DE            EC=3.1.4.43;
DE   AltName: Full=Glycerophosphodiester phosphodiesterase 3;
DE   AltName: Full=Glycerophosphodiester phosphodiesterase domain-containing protein 2;
DE   AltName: Full=Osteoblast differentiation promoting factor;
GN   Name=GDPD2; Synonyms=GDE3, OBDPF; ORFNames=UNQ1935/PRO4418;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=12933806; DOI=10.1074/jbc.M302867200;
RA   Yanaka N., Imai Y., Kawai E., Akatsuka H., Wakimoto K., Nogusa Y.,
RA   Kato N., Chiba H., Kotani E., Omori K., Sakurai N.;
RT   "Novel membrane protein containing glycerophosphodiester
RT   phosphodiesterase motif is transiently expressed during osteoblast
RT   differentiation.";
RL   J. Biol. Chem. 278:43595-43602(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Caudate nucleus, Colon mucosa, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Has glycerophosphoinositol inositolphosphodiesterase
CC       activity and specifically hydrolyzes glycerophosphoinositol, with
CC       no activity for other substrates such as glycerophosphoinositol 4-
CC       phosphate, glycerophosphocholine, glycerophosphoethanolamine, and
CC       glycerophosphoserine. Accelerates the program of osteoblast
CC       differentiation and growth. May play a role in remodeling of the
CC       actin cytoskeleton (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 1-(sn-glycero-3-phospho)-1D-myo-inositol +
CC       H(2)O = glycerol + 1D-myo-inositol 1-phosphate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasm. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes
CC       with the actin cytoskeleton. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HCC8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCC8-2; Sequence=VSP_042622;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9HCC8-3; Sequence=VSP_042623;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the glycerophosphoryl diester
CC       phosphodiesterase family. {ECO:0000305}.
CC   -!- CAUTION: The catalytic domain of GDPD2 is oriented
CC       extracellularly; Glycerophosphoinositol is hydrolyzed in the
CC       medium of cells overexpressing Gdpd2, whereas intracellular levels
CC       of glycerophosphoinositol is not affected. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91014.1; Type=Frameshift; Positions=397; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB048363; BAB13350.1; -; mRNA.
DR   EMBL; AY358986; AAQ89345.1; -; mRNA.
DR   EMBL; AK000214; BAA91014.1; ALT_FRAME; mRNA.
DR   EMBL; AK299255; BAG61286.1; -; mRNA.
DR   EMBL; AK301025; BAG62641.1; -; mRNA.
DR   EMBL; AK316035; BAH14406.1; -; mRNA.
DR   EMBL; AL139398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032009; AAH32009.1; -; mRNA.
DR   CCDS; CCDS14402.1; -. [Q9HCC8-1]
DR   CCDS; CCDS55437.1; -. [Q9HCC8-3]
DR   CCDS; CCDS55438.1; -. [Q9HCC8-2]
DR   RefSeq; NP_001164662.1; NM_001171191.1. [Q9HCC8-2]
DR   RefSeq; NP_001164663.1; NM_001171192.1. [Q9HCC8-3]
DR   RefSeq; NP_001164664.1; NM_001171193.1. [Q9HCC8-2]
DR   RefSeq; NP_060181.2; NM_017711.3. [Q9HCC8-1]
DR   UniGene; Hs.438712; -.
DR   ProteinModelPortal; Q9HCC8; -.
DR   SMR; Q9HCC8; -.
DR   BioGrid; 120207; 4.
DR   IntAct; Q9HCC8; 41.
DR   MINT; MINT-1426959; -.
DR   iPTMnet; Q9HCC8; -.
DR   PhosphoSitePlus; Q9HCC8; -.
DR   BioMuta; GDPD2; -.
DR   DMDM; 74752794; -.
DR   PeptideAtlas; Q9HCC8; -.
DR   PRIDE; Q9HCC8; -.
DR   DNASU; 54857; -.
DR   Ensembl; ENST00000374382; ENSP00000363503; ENSG00000130055. [Q9HCC8-1]
DR   Ensembl; ENST00000453994; ENSP00000414019; ENSG00000130055. [Q9HCC8-3]
DR   Ensembl; ENST00000536730; ENSP00000445982; ENSG00000130055. [Q9HCC8-2]
DR   Ensembl; ENST00000538649; ENSP00000444601; ENSG00000130055. [Q9HCC8-2]
DR   GeneID; 54857; -.
DR   KEGG; hsa:54857; -.
DR   UCSC; uc004dyh.4; human. [Q9HCC8-1]
DR   CTD; 54857; -.
DR   GeneCards; GDPD2; -.
DR   HGNC; HGNC:25974; GDPD2.
DR   MIM; 300940; gene.
DR   neXtProt; NX_Q9HCC8; -.
DR   OpenTargets; ENSG00000130055; -.
DR   PharmGKB; PA134907263; -.
DR   GeneTree; ENSGT00510000046457; -.
DR   HOGENOM; HOG000232101; -.
DR   HOVERGEN; HBG081551; -.
DR   InParanoid; Q9HCC8; -.
DR   KO; K01124; -.
DR   OMA; IKALHQD; -.
DR   OrthoDB; EOG091G043H; -.
DR   PhylomeDB; Q9HCC8; -.
DR   TreeFam; TF313692; -.
DR   GenomeRNAi; 54857; -.
DR   PRO; PR:Q9HCC8; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000130055; -.
DR   CleanEx; HS_GDPD2; -.
DR   Genevisible; Q9HCC8; HS.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro.
DR   GO; GO:0047394; F:glycerophosphoinositol inositolphosphodiesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0090527; P:actin filament reorganization; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:InterPro.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR004129; GlyceroP-diester-Pdiesterase.
DR   InterPro; IPR030395; GP_PDE_dom.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   PANTHER; PTHR23344; PTHR23344; 1.
DR   Pfam; PF03009; GDPD; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS51704; GP_PDE; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Glycoprotein; Hydrolase; Membrane; Metal-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    539       Glycerophosphoinositol
FT                                inositolphosphodiesterase GDPD2.
FT                                /FTId=PRO_0000251934.
FT   TOPO_DOM      1     38       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     39     59       Helical. {ECO:0000255}.
FT   TOPO_DOM     60     85       Extracellular. {ECO:0000255}.
FT   TRANSMEM     86    106       Helical. {ECO:0000255}.
FT   TOPO_DOM    107    121       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TOPO_DOM    143    154       Extracellular. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
FT   TOPO_DOM    176    188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical. {ECO:0000255}.
FT   TOPO_DOM    210    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical. {ECO:0000255}.
FT   TOPO_DOM    512    539       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      224    479       GP-PDE.
FT   METAL       256    256       Divalent metal cation. {ECO:0000255}.
FT   METAL       258    258       Divalent metal cation. {ECO:0000255}.
FT   METAL       271    271       Divalent metal cation. {ECO:0000255}.
FT   CARBOHYD    442    442       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     79       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042622.
FT   VAR_SEQ     436    436       K -> KDRFLLPAQAGLKLLASSNLPASASQSAGITGLSHC
FT                                PPQPPGYKHELSHLAM (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042623.
FT   CONFLICT    418    418       E -> G (in Ref. 3; BAA91014).
FT                                {ECO:0000305}.
SQ   SEQUENCE   539 AA;  61729 MW;  8271C3A74766D540 CRC64;
     MAESPGCCSV WARCLHCLYS CHWRKCPRER MQTSKCDCIW FGLLFLTFLL SLSWLYIGLV
     LLNDLHNFNE FLFRRWGHWM DWSLAFLLVI SLLVTYASLL LVLALLLRLC RQPLHLHSLH
     KVLLLLIMLL VAAGLVGLDI QWQQEWHSLR VSLQATAPFL HIGAAAGIAL LAWPVADTFY
     RIHRRGPKIL LLLLFFGVVL VIYLAPLCIS SPCIMEPRDL PPKPGLVGHR GAPMLAPENT
     LMSLRKTAEC GATVFETDVM VSSDGVPFLM HDEHLSRTTN VASVFPTRIT AHSSDFSWTE
     LKRLNAGSWF LERRPFWGAK PLAGPDQKEA ESQTVPALEE LLEEAAALNL SIMFDLRRPP
     QNHTYYDTFV IQTLETVLNA RVPQAMVFWL PDEDRANVQR RAPGMRQIYG RQGGNRTERP
     QFLNLPYQDL PLLDIKALHK DNVSVNLFVV NKPWLFSLLW CAGVDSVTTN DCQLLQQMRY
     PIWLITPQTY LIIWVITNCV STMLLLWTFL LQRRFVKKRG KTGLETAVLL TRINNFMME
//
